Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
Qiming Duan, Sarah McMahon, Priti Anand, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 390
Open Access | Times Cited: 233

Showing 26-50 of 233 citing articles:

Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out
Joshua Zent, Lian‐Wang Guo
Cellular Physiology and Biochemistry (2018) Vol. 49, Iss. 3, pp. 848-868
Open Access | Times Cited: 95
Epigenetics in Cardiac Fibrosis
Marina Barreto Felisbino, Timothy A. McKinsey
JACC Basic to Translational Science (2018) Vol. 3, Iss. 5, pp. 704-715
Open Access | Times Cited: 94
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases
Ewelina Kulikowski, Brooke D. Rakai, Norman C.W. Wong
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 223-245
Open Access | Times Cited: 91
Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis
Shuai Song, Liang Liu, Yi Yu, et al.
Journal of Molecular and Cellular Cardiology (2018) Vol. 127, pp. 83-96
Closed Access | Times Cited: 86
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
José Luis Morgado‐Pascual, Sandra Rayego‐Mateos, Lucía Tejedor-Santamaria, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 83
BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo
Jing Mu, Donghong Zhang, YunLi Tian, et al.
Journal of Molecular and Cellular Cardiology (2020) Vol. 149, pp. 1-14
Open Access | Times Cited: 76
Role of the Epigenome in Heart Failure
Roberto Papait, Simone Serio, Gianluigi Condorelli
Physiological Reviews (2020) Vol. 100, Iss. 4, pp. 1753-1777
Closed Access | Times Cited: 71
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation
Zhiqing Liu, Haiying Chen, Pingyuan Wang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 10, pp. 5242-5256
Open Access | Times Cited: 70
Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB–P300–BRD4 axis
Xuesong Li, Ruigong Zhu, Hong Jiang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 5, pp. 2280-2299
Open Access | Times Cited: 68
Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779
Hairuo Lin, Yingqi Zhu, Cankun Zheng, et al.
Circulation (2021) Vol. 143, Iss. 23, pp. 2277-2292
Open Access | Times Cited: 65
Single-cell transcriptomics for the assessment of cardiac disease
Antonio M. A. Miranda, Vaibhao Janbandhu, Henrike Maatz, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 5, pp. 289-308
Open Access | Times Cited: 62
Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study
Stephen J. Nicholls, Gregory G. Schwartz, Kevin A. Buhr, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 59
Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
Timothy A. McKinsey, Roger Foo, Chukwuemeka George Anene-Nzelu, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3482-3498
Open Access | Times Cited: 39
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site
Zhiqing Liu, Yi Li, Haiying Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2388-2408
Open Access | Times Cited: 38
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 38
The heterocellular heart: identities, interactions, and implications for cardiology
Achim Lother, Peter Köhl
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 28
TEA domain transcription factor 1 (TEAD1) induces cardiac fibroblasts cells remodeling through BRD4/Wnt4 pathway
Shuai Song, Xiaokai Zhang, Zihang Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
Zhuyubing Fang, Umar Raza, Jia Song, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 9
Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells
Sadhan Das, Parijat Senapati, Zhuo Chen, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 87
cellHarmony: cell-level matching and holistic comparison of single-cell transcriptomes
Erica A. K. DePasquale, Daniel Schnell, Phillip J. Dexheimer, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 21, pp. e138-e138
Open Access | Times Cited: 66
DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure
Mark E. Pepin, Stavros G. Drakos, Chae‐Myeong Ha, et al.
AJP Heart and Circulatory Physiology (2019) Vol. 317, Iss. 4, pp. H674-H684
Open Access | Times Cited: 65
p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization
Jinjin Peng, Jiacheng Li, Jing Huang, et al.
Theranostics (2019) Vol. 9, Iss. 26, pp. 8344-8361
Open Access | Times Cited: 64
Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function
Soo Young Kim, Xin Zhang, Gabriele G. Schiattarella, et al.
Circulation (2020) Vol. 142, Iss. 24, pp. 2356-2370
Open Access | Times Cited: 63
Epigenomes in Cardiovascular Disease
Manuel Rosa‐Garrido, Douglas J. Chapski, Thomas M. Vondriska
Circulation Research (2018) Vol. 122, Iss. 11, pp. 1586-1607
Open Access | Times Cited: 62
BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient mice
Gaëlle Auguste, Leila Rouhi, Scot J. Matkovich, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 9, pp. 4740-4758
Open Access | Times Cited: 59

Scroll to top